A Pakistani activist who lost a brother and a son in a CIA drone attack has been freed after a mysterious abduction earlier this month.
Kareem Khan — who had been set to testify in Europe about drone warfare — was taken from his home Feb. 5 by nearly 20 men, eight of whom were in police uniform. “We believe it likely to have been agencies connected to the government, police, counterterrorism force, or military, intelligence services,” emailed Zarmeeneh Rahim, a lawyer for the Foundation for Fundamental Rights, which represents Khan. “His work is an embarrassment to the Pakistani government and the military, and they have ample reason to silence him.”
Khan was beaten repeatedly on the soles of his feet, interrogated about his contact with drone victims, and driven around blindfolded. On Friday, his captors threw him from a van after ordering him not to speak with the media.
Although the kidnapping was apparently intended to intimidate Khan from speaking out, Rahim said he plans to leave for Europe Saturday as planned.
In 2010, Khan sued the CIA, urging Pakistani courts to execute the agency’s Islamabad station chief for his role in the drone attack that killed his family members. U.S. government leaders said the strike was targeted at a Taliban commander they believed to be in the house. Khan claimed he did not know the commander and that he was not in the home at the time.
Khan — who is slated to speak with German, Dutch, and British authorities about the drone strikes — is also suing the Pakistani government for failing to investigate the strike that killed his family. Rahim said he is trying to change perceptions of his region, Waziristan, to prevent further violence. “Even within Pakistan, there is a lot of misinformation, misunderstanding about the people of Waziristan, their presumed support for terrorists,” Rahim said. “The people of the tribal areas are seen as either Pakistani Taliban, or their supporters, and seen as inviting or deserving of the violence that is visited upon them daily.”
- 1 The Story of 2016: Republicans Feeling “Betrayed” by Their Leaders
- 2 How Washington Derailed Amtrak
- 3 Hillary Clinton Won (But It Won’t Always Be This Way)
- 4 The Number of U.S. Farmers Markets Has Nearly Doubled in the Last Five Years
- 5 Army Lt. Gen. Sean MacFarland to Lead U.S. Fight Against ISIS
What We're Following See More »
In a release Tuesday afternoon, the White House announced that President Obama has commuted and/or reduced the sentences of another 111 convicted criminals, mostly convicted of drug possession or trafficking. About 35 were serving life sentences.
Senate Judiciary Committee Chairman Chuck Grassley (R-IA) said Monday he'd now be willing to hold a hearing on Supreme Court nominee Merrick Garland in a lame-duck session of Congress. While he said he wouldn't push for it, he said if "Hillary Clinton wins the White House, and a majority of senators convinced him to do so," he would soften his previous opposition.
In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.
“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”
The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.